NCT02433210View on ClinicalTrials.gov

A Clinical Study Comparing Basic Performance and Hemocompatibility of 3 Different Dialyzers in Hemodialysis Patients

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

November 30, 2017

Study Completion Date

August 31, 2018

Conditions
End Stage Renal Disease (ESRD)
Interventions
DEVICE

ELISIO-15H

Each patient to undergo 3 successive hemodialysis/week with this dialyzer.

DEVICE

Revaclear

Each patient to undergo 3 successive hemodialysis/week with this dialyzer.

DEVICE

Optiflux

Each patient to undergo 3 successive hemodialysis/week with this dialyzer.

Trial Locations (1)

65201

Dialysis Clinic Incorporated, Columbia

Sponsors

Collaborators (1)

Nipro Medical Corporation
All Listed Sponsors
collaborator

Nipro Medical Corporation

INDUSTRY

collaborator

Dialysis Clinic, Inc.

INDUSTRY

lead

University of Missouri-Columbia

OTHER